Stock & Company Details
Moderna Inc $MRNA
Price:
46,691,331
397M
$25B
52 Week High:
$66.15
10 Day Average Volume:
42,760,466
-7.84
50 Day Moving Average:
$156.49
52 Week Low:
$43.74
30 Day Average Volume:
49,506,373
$4.94
2021-02-05
0.95
30 Day Change:
13%
3 Month Change:
-0.32%
Health Technology
MRNA technical indicators
Latest Moderna Inc (MRNA) technical indicators as of 2026-07-17: RSI, MACD, moving averages (SMA & EMA), Bollinger Bands, Stochastic, ADX, ATR, CCI, OBV and ROC.
RSI 14:
46.07 3.5%
MACD:
2.77 22.7%
SMA 50:
$57.09 0.5%
SMA 200:
$43.39 0.4%
EMA 20:
$66.33 0.7%
Bollinger Bands:
82.18 / 54.99
Stochastic:
18.47 36.1%
ADX 14:
30.82 6.6%
ATR 14:
4.71 3.9%
CCI 20:
-80.59 65.3%
OBV:
28.61M 13.7%
ROC 12:
-11.72% 24.8%
Select a strategy to see its performance
Backtested on this stock over recent history.
| Strategy | Trend | Return | Win rate |
|---|---|---|---|
| MACD Momentum Momentum Buy when MACD turns positive (crosses above zero) and RSI confirms momentum above 50; sell when MACD falls back below zero. | – | – | |
| RSI Reversal Mean reversion Buy when RSI falls below 30 (oversold), sell when it climbs above 70 (overbought). | – | – | |
| Volatility Breakout Volatility Buy when price closes above the upper Bollinger Band, sell on reversion to the 20-day average. | – | – | |
| Strong-Trend Pullback Trend + timing In strongly trending stocks (ADX above 25), buy short-term dips (Stochastic below 30) and sell into overbought (above 80). | – | – |
Overview
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its COVID-19 vaccine, which was authorized in the United States in December 2020. Moderna had 39 mRNA development candidates in clinical trials as of mid-2023. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
Finance Bot
Ask your questions
Start by typing a question below.
